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defined at the TPS includes the fixation system, the program 
calculates the whole path as tissue; although for conformal 
radiotherapy heterogeneity contours can be drawn in the BEV, there is 
no way in doing the same in the calculation slice as it would be 
necessary for treatments involving large areas with low or high 
densities as lung treatments; large couch rotations are not addressed 
by the system. 
Conclusions: Diamond has proven to be an efficient tool to perform 
independent verifications of TPS calculations. From our initial 
experience we have found that some minor changes in the program 
such as an improvement in the introduction of all the desired 
calculation points or the possibility of modification of the calculation 
slice (removing support structures, adding heterogeneities) would be 
very helpful to users.  
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Purpose/Objective: The use of Volumetric Modulated Arc Therapy 
(VMAT) treatment plans for radiotherapy treatments of head and neck 
patients is increasing mainly due to shorter treatment times compared 
to IMRT. However, accurate multileaf collimator (MLC) leaf positioning 
plays an essential role in the effective implementation of VMAT. The 
aim for the present work is to investigate the sensitivity of a new 
patient specific QA-measurement system for QA during treatments 
with respect to MLC leaf positioning errors.  
Materials and Methods: Ten head and neck patients previously 
planned and treated with a VMAT technique were used in the study. 
The original plans were exported and the leaf positions were changed 
to simulate five different systematic positioning errors of the MLC-
banks. That is + 0.2 mm and + 0.5 mm of all leaf positions in each leaf 
bank (X1 and X2). Negative and positive errors make the leaf end-to-
end distance smaller and larger, respectively. The fifth plan simulated 
a random error of each leaf in each control point with a standard 
deviation of 0.5 mm. After the MLC leaf positioning errors were 
introduced the plans were re-imported and re-calculated in the 
treatment planning system. Measurements, with a Delta4PT and a 
Delta4AT system, for the modified plans, were compared with 
calculated doses of the original plans and with each other. The 
agreement between calculation and measurement was evaluated using 
gamma index with 3%/3 mm and 3%/2 mm criteria.  
Results: Comparing the original treatment plans with the plans 
representing MLC leaf positioning errors show that the target coverage 
decreases significantly for + 0.5 mm leaf position errors and the dose 
to the organs at risk increases significantly. The sensitivity of the 
upstream detector system was large for all plans with clinical relevant 
MLC leaf positioning errors.  
Conclusions: The capability of detecting clinical relevant leaf 
positioning errors with the upstream detector system was good.  
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Purpose/Objective: After certain types of brain surgery part of the 
skull bone may require to be replaced by a titanium plate. If such 
patients have a tumour recurrence Gamma Knife treatment may be 
required. The effects of a 0.5mm titanium plate on dosimetry were 
investigated. 
Materials and Methods: On a Gamma KnifePerfexion the spherical ABS 
phantom was used to measure dose with and without thetitanium 
plate (superior, one 16mm shot) and with titanium plate only within 
halfthe field. EBT 2 film was exposed directlyunder the plate and in a 
plane in 1cm wax. to 5Gy. Transmission from a single sector was 
measured with a 0.125cc ion chamber (PTW 31010). The central slab 
from the ABS phantom was placed on a Perspex block of 15x15x20cm3 
in order to position the chamber centre 5mm beneath the plate 
surface. Chamber,holder and phantom where fixed on the eXtend 
system and a CT scan performed. This arrangement was irradiated 
with 2 Gy to the 100% isodose from a single 16mm sector to the centre 
of the ion chamber as scanned(no absorber material), with the 
titanium plate directly in contact with the phantom surface, and with 
1cm air gap Thetransmission of the titanium plate was also measured 
on a 6MV Linac with a10x10 and a 4x4cm field and SSD 100cm with a 
Farmer type chamber in 5cm water and on a orthovoltage unit with 
220kV (6x6cm, FSD 53cm).  
Results: On film only a dose increase of a few percent directly under 
the plate was measureable with the film scanner. No difference was 
observed on the film at 1cm depth between irradiation with or 
without the titanium plate and no difference observed for the half 
covered area. Single sector measured transmission with the ion 
chamber showed an absorption of 0.7% when a1cm gap of air was left 
between titanium plate and the surface. A dose increase of 0.4% was 
measured when the titanium plate was placed directly in contact to 
the slab of the chamber holder. On the 6MV Linac the absorption of 
the titanium plate was 0.6% and 0.8% for the 10x10 respectively 
4x4cm field respectively. On the 220kV X-ray unit an absorption of 
5.4% was measured for the 0.5mm titanium plate. 
Conclusions: Absorption due to the Titanium plate used for skull bone 
replacement seems to be minimal for Cobalt-60 energy. The dose 
increase directly after the titanium plate is measureable but due to 
the multi circular beam arrangement of the Gamma Knife the effect is 
spread. Special care should be given to targets with a distance of less 
than 3mm to the titanium implant due to the dose increase when all 
beams intersect at the same place.  
   
EP-1171   
Testing the feasibility of integration of an in vivo dosimetry 
procedure in quality assurance of pelvic 3DCRT 
M. Russo1, A. Anitori1, F. Greco2, M.S. D'Ambrosio3, M. Carcaterra3, V. 
Burla3, A. Piermattei4 
1Ospedale Belcolle - AUSL VT, UU.OO. Fisica Sanitaria e Radioterapia, 
Viterbo, Italy  
2Università Cattolica Sacro Cuore, U.O. Fisica Sanitaria, Roma, Italy  
3Ospedale Belcolle - AUSL VT, U.O. Radioterapia, Viterbo, Italy  
4Università Cattolica Sacro Cuore, Istituto di Fisica e U.O. Fisica 
Sanitaria, Roma, Italy  
 
Purpose/Objective: The demand for safety and quality assurance in 
RT is becoming increasingly urgent. This is a need felt by professionals 
involved, caused by the growing complexity of RT techniques and 
technologies involved in treatment delivery, as well as by patients, 
because of the increasing attention paid by non- specialist press to RT 
accidents. As an associate member of a National Project financed by 
the National Institute of Nuclear Physics, aiming to development of in 
vivo dosimetry (IVD) procedures for RT, our Institution have 
participated in testing the IVD procedure and software, specific for 
3DCRT. Here we propose the preliminary results of a trial aiming to 
IVD integration in quality management of pelvic RT. 
Materials and Methods: 15 consecutive patients undergone to 3DCRT 
for pelvic cancer (prostate, rectum or gynecologic tumors) were 
selected. A personalized 3DCRT treatment plan was prepared for all of 
them, consisting of a set of 4 or 5 MLC conformed beams (open or 
wedged beams), with an isocentric prescription dose/fraction of 1.8 
Gy, (number of fractions ranging between 25 and 43). DRRs of a 
couple of square orthogonal isocentric fields were also obtained for 
patient setup verification on linac couch. Geometric and dosimetric 
plan data were then transferred to the R&V Network, to make them 
allowable to both linac interface and IVD software. An integrated 
approach, based on scheduled setup verifications (SVs) and IVD checks 
has been tested for each selected patient during the course of RT, 
consisting of: i) a comparison between the EPID images of the couple 
of orthogonal beams and the corresponding DRRs before treatment 
delivery and ii) the calculation for each field of R ratio between the 
TPS calculated isocentric dose and the delivered dose during the 
treatment session.  
Results: As SVs and IVD checks were scheduled on different treatment 
days, total amount of time required for tests during a treatment 
session resulted compatible with staff workload. 
For all tested patients SVs showed average deviations equal to 2.9 
mm, with every single value below the action level (±4 mm), 
confirming a day by day setup reproducibility inside quality standard. 
A total of 176 IVD tests were performed on 44 different sessions. In 
84% of the IVD checks the results were within the accepted tolerance 
of 5% for R. In the 16% of cases, 1 or more R values resulted out of 
tolerance. The average R value on each of the 44 sessions resulted 
within tolerance range in 93% of cases. A more detailed analysis of 
unsuccessful tests revealed the following causes for dose discrepancy: 
presence of gas pockets, attenuating media on beam axis at beam 
exit, random loss of patient setup during treatment.  
Conclusions: An integrated approach based on SVs and an IVD tests 
can be a valuable tool in quality management of pelvic 3DCRT: in case 
of discrepancy between delivered and planned doses, IVD gives to RT 
team the chance to analyze and program adequate corrections in 
further RT sessions. 
   
 
 
 
